Sezary Syndrome Market - Top Companies and Manufacturers

  • Report ID: 4996
  • Published Date: Aug 01, 2024
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Global Sezary Syndrome Market

    • GSK plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • The Bristol Myers Squibb Company
    • F-Hoffmann La Roche Ltd.
    • Pfizer Inc.
    • Novartis AG
    • Johnson and Johnson Services, Inc.
    • Asher Biotherapeutics, Inc.
    • Be Biopharma
    • Eisai Co., Ltd.
    • Seagen Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • The Japan-based Eisai Co., Ltd. has received approval to market and manufacture Remitoro for the treatment of relapsed or refractory PTCL or CTCL. The drug Remitoro is considered a high-need drug.
  • Seagen Inc. has announced new data for ADCETRIS will be presented at the 64th Annual Meeting and Exposition of the American Society of Hematology (ASH). An updated and interim efficacy and safety clinical trial study for ADCETRIS in classical Hodgkin lymphoma (cHL) and other CD30-expressing lymphomas as well as other rare cancers was presented in the abstracts, including five oral presentations.

Author Credits:  Radhika Pawar


  • Report ID: 4996
  • Published Date: Aug 01, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of sezary syndrome is assessed at USD 804.51 Million.

The sezary syndrome market size was over USD 747.96 Million in 2023 and is anticipated to reach USD 2.13 Billion by the end of 2036, growing at around 8.4% CAGR during the forecast period i.e., between 2024-2036. Increasing number of patients suffering from sezary syndrome, a rise in healthcare expenditure, and a growing awareness about the disease.

North America industry is set to hold 37% of the revenue share by 2036, owing to rising medical facilities along with advance healthcare systems in the region.

GSK plc, The Bristol Myers Squibb Company, F-Hoffmann La Roche Ltd., Pfizer Inc., Novartis AG, Johnson and Johnson Services, Inc., Asher Biotherapeutics, Inc., Be Biopharma, Eisai Co., Ltd., Seagen Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample